These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8600463)

  • 21. Suppression of EJ cells tumorigenicity.
    Tone T; Kashani-Sabet M; Funato T; Shitara T; Yoshida E; Kashfian BI; Horng M; Fodstadt O; Scanlon KJ
    In Vivo; 1993; 7(6A):471-6. PubMed ID: 8193263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer.
    Kijima H; Yamazaki H; Nakamura M; Scanlon KJ; Osamura RY; Ueyama Y
    Int J Oncol; 2004 Mar; 24(3):559-64. PubMed ID: 14767540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hammerhead ribozyme specifically inhibits mutant K-ras mRNA of human pancreatic cancer cells.
    Tsuchida T; Kijima H; Oshika Y; Tokunaga T; Abe Y; Yamazaki H; Tamaoki N; Ueyama Y; Scanlon KJ; Nakamura M
    Biochem Biophys Res Commun; 1998 Dec; 253(2):368-73. PubMed ID: 9878544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice.
    Zhang YA; Nemunaitis J; Scanlon KJ; Tong AW
    Gene Ther; 2000 Dec; 7(23):2041-50. PubMed ID: 11175317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis.
    Abounader R; Lal B; Luddy C; Koe G; Davidson B; Rosen EM; Laterra J
    FASEB J; 2002 Jan; 16(1):108-10. PubMed ID: 11729097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects on tumor cells of ribozymes that cleave the RNA transcripts of human papillomavirus type 18.
    Chen Z; Kamath P; Zhang S; St John L; Adler-Storthz K; Shillitoe EJ
    Cancer Gene Ther; 1996; 3(1):18-23. PubMed ID: 8785706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of apoptosis in oral cancer cells by an anti-bcl-2 ribozyme delivered by an adenovirus vector.
    Gibson SA; Pellenz C; Hutchison RE; Davey FR; Shillitoe EJ
    Clin Cancer Res; 2000 Jan; 6(1):213-22. PubMed ID: 10656452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype.
    Albino AP; Nanus DM; Mentle IR; Cordon-Cardo C; McNutt NS; Bressler J; Andreeff M
    Oncogene; 1989 Nov; 4(11):1363-74. PubMed ID: 2682463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Fas-mediated apoptosis in mouse insulinoma betaTC-3 cells via an anti-Fas ribozyme.
    Klein D; Ricordi C; Pugliese A; Pastori RL
    Hum Gene Ther; 2000 May; 11(7):1033-45. PubMed ID: 10811232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of anti-HPV16 E6-ribozyme on the proliferation and apoptosis of human cervical cancer cell line CaSKi.
    Zheng YF; Rao ZG; Zhang JR
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Jun; 22(6):496-8. PubMed ID: 12297466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of interleukin 1 alpha, interleukin 6, and tumor necrosis factor alpha genes in human melanoma clones is associated with that of mutated N-RAS oncogene.
    Castelli C; Sensi M; Lupetti R; Mortarini R; Panceri P; Anichini A; Parmiani G
    Cancer Res; 1994 Sep; 54(17):4785-90. PubMed ID: 8062279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells.
    Suzuki T; Anderegg B; Ohkawa T; Irie A; Engebraaten O; Halks-Miller M; Holm PS; Curiel DT; Kashani-Sabet M; Scanlon KJ
    Gene Ther; 2000 Feb; 7(3):241-8. PubMed ID: 10694801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of platinum-DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells.
    Materna V; Liedert B; Thomale J; Lage H
    Int J Cancer; 2005 Jun; 115(3):393-402. PubMed ID: 15688364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of gene regulatory elements for selective gene expression in human melanoma cells.
    Artuc M; Nürnberg W; Czarnetzki BM; Schadendorf D
    Biochem Biophys Res Commun; 1995 Aug; 213(2):699-705. PubMed ID: 7646526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrovirus-mediated transfer of anti-MDR1 ribozymes fully restores chemosensitivity of P-glycoprotein-expressing human lymphoma cells.
    Wang FS; Kobayashi H; Liang KW; Holland JF; Ohnuma T
    Hum Gene Ther; 1999 May; 10(7):1185-95. PubMed ID: 10340550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A potential therapeutic application of hairpin ribozymes: in vitro and in vivo studies of gene therapy for hepatitis C virus infection.
    Welch PJ; Tritz R; Yei S; Leavitt M; Yu M; Barber J
    Gene Ther; 1996 Nov; 3(11):994-1001. PubMed ID: 9044745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
    Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
    Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibition.
    Zhou C; Bahner I; Rossi JJ; Kohn DB
    Antisense Nucleic Acid Drug Dev; 1996; 6(1):17-24. PubMed ID: 8783792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells.
    Collis SJ; Tighe A; Scott SD; Roberts SA; Hendry JH; Margison GP
    Nucleic Acids Res; 2001 Apr; 29(7):1534-8. PubMed ID: 11266555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.